Rosh Pina, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) — IR-MED Inc. , (“IR-MED” or the “Company”) (OTCQB:IRME)
Development of Innovative Healthcare Technology
IR-MED Inc., a leading developer of noninvasive artificial intelligence (AI) driven spectrographic analysis technology, has announced the start of a usability study for its groundbreaking product, PressureSafe™. The study, taking place at Methodist Healthcare in San Antonio, Texas, is focused on evaluating the safety and efficacy of the PressureSafe Device for early detection of pressure injuries in individuals with various skin tones, including those with dark skin tones.
Methodist Healthcare is known for its exceptional healthcare services and is trusted by a large number of patients in the region. With a wide network of care facilities, including hospitals, surgery centers, ERs, and family health clinics, the organization serves a significant number of patients each year, providing essential medical care to the community.
Impact on Individuals
For individuals participating in the usability study at Methodist Healthcare, the use of PressureSafe™ represents a significant advancement in healthcare technology. The innovative AI-driven spectrographic analysis technology has the potential to revolutionize the early detection of pressure injuries, particularly in individuals with darker skin tones. This could lead to better outcomes for patients, as injuries can be detected and addressed earlier, improving overall health and quality of life.
Global Impact
The development and implementation of the PressureSafe Device by IR-MED Inc. have the potential to have a profound impact on healthcare systems worldwide. By utilizing AI-driven technology for early detection of pressure injuries, healthcare providers can improve patient outcomes, reduce healthcare costs, and enhance the overall quality of care. This innovative approach to healthcare technology could set a new standard for patient safety and treatment.
Conclusion
IR-MED Inc.’s usability study for PressureSafe™ at Methodist Healthcare marks a significant milestone in the advancement of healthcare technology. The innovative AI-driven spectrographic analysis platform has the potential to revolutionize the early detection of pressure injuries, benefiting individuals with various skin tones and making a positive impact on healthcare systems globally. This breakthrough underscores the importance of investing in cutting-edge technology to improve patient outcomes and enhance the quality of care.
